Response: Although we acknowledge the applicant's concerns regarding the descriptor for C1739, we do not agree that the device category code should be withdrawn and replaced with a new code effective January 1, 2026, for the following reasons: First, per the applicant's request prior to CY 2026 rulemaking, CMS revised the descriptor for C1739 to read, effective October 1, 2025: Tissue marker, uniquely detectable and identifiable with probe/sensor, any method (implantable), with delivery system
Inactive Ingredients and Their Role The solution for injection includes stabilizers and preservatives along with saline to maintain the product's stability and sterility and ensure safety during administration
B12 injections can help protect nerve cells, promote the regeneration of damaged nerves, and alleviate symptoms of peripheral neuropathy, which may occur in B12 deficiency
Within scientific literature, this material has been the subject of ongoing investigation relating to cellular signalling pathways, metabolic research models, and enzyme interaction studies
This includes publicly reporting the overall score and four numerator components, in alignment with the approach taken by the Hospital OQR Program for publicly reporting a similar version of Emergency Care Access & Timeliness eCQM
